SiSaf Announces Positive Preclinical Data in its SiS-ADO2 siRNA Program to Treat Rare Genetic Bone Disorder Osteopetrosis

Data presented by academic collaborator from the University of L'Aquila, Italy at the American Society of Bone and Mineral Research (ASBMR) 2022 Annual Meeting, 9-12 September, Austin, Texas

Related Keywords

Italy ,Guildford ,Surrey ,United Kingdom ,Laquila ,Abruzzo ,United States ,Texas ,American ,Nissim Torabi ,Anna Teti ,Ashkan Dehsorkhi ,Sisaf Bio ,Suzanne Saffie Siebert ,Chris Burns ,Piergiorgio Patrizii ,Anna Maria Teti ,Kostenloser Wertpapierhandel ,Flavia Maria Sutera ,Antonio Maurizi ,Michael Wels ,Department Of Biotechnological ,Linkedin ,Prnewswire Sisaf Ltd ,Twitter ,Sisaf Ltd ,Clinical Sciences ,Mineral Research ,American Society Of Bone ,United Kingdom Future Fund ,American Society ,Saf Ltd ,Autosomal Dominant Osteopetrosis ,Professor Anna Maria Teti ,Applied Clinical Sciences ,Professor Teti ,Nissim Torabi Pour ,Vickers Venture Partners ,United Kingdom Future ,Sisaf ,Nnounces ,Positive ,Reclinical ,Data ,Fido2 ,Dirna ,Program ,Treat ,Mare ,Enetic ,One ,Disorder ,Osteopetrosis ,